Journal of Infection
Volume 61, Issue 3 , Pages 219-227 , September 2010

Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia

  • Nan-Yao Lee

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Tsung Chain Chang

      Affiliations

    • Medical Laboratory Science and Biotechnology, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Chi-Jung Wu

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • Graduate Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Chia-Ming Chang

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Hsin-Chun Lee

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • Department of Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • Graduate Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Po-Lin Chen

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Graduate Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Ching-Chi Lee

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Department of Emergency Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Graduate Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Nai-Ying Ko

      Affiliations

    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • Department of Nursing, National Cheng Kung University Medical College, Tainan, Taiwan
    • ,
  • Wen-Chien Ko

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan
    • Department of Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
    • Division of Clinical Research, National Health Research Institutes, Tainan, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, National Cheng Kung University Hospital, #138, Sheng Li Road, Tainan, 704, Taiwan. Tel.: +886 6 235 3535x3596; fax: +886 6 275 2038.

,Accepted 3 July 2010.

References 

  1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148–165
  2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–951
  3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582
  4. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis. 2000;31:690–697
  5. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271–1281
  6. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–1263
  7. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73:355–363
  8. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis. 2003;36:1268–1274
  9. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8:687–693
  10. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471–3484
  11. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991;29:277–282
  12. Ko WC, Lee NY, Su SC, Dijkshoorn L, Vaneechoutte M, Wang LR, et al. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus – A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol. 2008;46:2052–2059
  13. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223–2228
  14. McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med. 1962;110:847–855
  15. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963
  16. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37:230–237
  17. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of critical care Medicine. Chest. 1992;101:1644–1655
  18. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med. 1993;19:137–144
  19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140
  20. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006;43(Suppl. 2):S43–S48
  21. Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med. 2002;162:2469–2477
  22. VonGraevenitz A. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In:  Murray PR BE,  Pfaller MA,  Tenover FC,  Yolken RH editor. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology; 1995;p. 520–532
  23. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex by sequence analysis of the 16S–23S rRNA gene spacer region. J Clin Microbiol. 2005;43:1632–1639
  24. Clinical and Laboratory Standard Institute . Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Wayne, PA, USA: CLSI; 2006;M100–MS116
  25. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore). 1995;74:340–349
  26. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45:329–337
  27. Ibrahim A, Gerner-Smidt P, Liesack W. Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol. 1997;47:837–841
  28. Dortet L, Legrand P, Soussy CJ, Cattoir V. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol. 2006;44:4471–4478
  29. Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A, et al. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother. 2008;62:1130–1137
  30. Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, Garaizar J, et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol. 1996;34:1519–1525
  31. Koeleman JG, van der Bijl MW, Stoof J, Vandenbroucke-Grauls CM, Savelkoul PH. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2001;22:284–288
  32. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol. 2001;39:228–234

☆ This study was presented in part at the Annual Meeting of the Infectious Disease Society of Taiwan, Taipei, Taiwan, January 12–13, 2008.

PII: S0163-4453(10)00185-4

doi: 10.1016/j.jinf.2010.07.002

Journal of Infection
Volume 61, Issue 3 , Pages 219-227 , September 2010

Article Tools

* Image Usage & Resolution